Clene (CLNN) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart

CLNN Stock Forecast

Clene stock forecast is as follows: an average price target of $10.00 (represents a 144.50% upside from CLNN’s last price of $4.09) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

CLNN Price Target

The average price target for Clene (CLNN) is $10.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $10.00. This represents a potential 144.50% upside from CLNN's last price of $4.09.

CLNN Analyst Ratings

Buy

According to 6 Wall Street analysts, Clene's rating consensus is 'Buy'. The analyst rating breakdown for CLNN stock is 0 'Strong Buy' (0.00%), 6 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Clene Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
May 02, 2022	Sumant Kulkarni	Canaccord Genuity	$10.00	$2.93	241.30%	144.50%

Row per page

Go to

The latest Clene stock forecast, released on May 02, 2022 by Sumant Kulkarni from Canaccord Genuity, set a price target of $10.00, which represents a 241.30% increase from the stock price at the time of the forecast ($2.93), and a 144.50% increase from CLNN last price ($4.09).

Clene Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	-
Avg Price Target	-	-	-
Last Closing Price	$4.09	$4.09	$4.09
Upside/Downside	-100.00%	-100.00%	-100.00%

In the current month, the average price target of Clene stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Clene's last price of $4.09. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 04, 2024	Canaccord Genuity	Buy	Buy	Hold
Sep 17, 2024	H.C. Wainwright	Buy	Buy	Hold
Sep 10, 2024	EF Hutton	-	Buy	Initialise
Aug 06, 2024	Rodman & Renshaw	Buy	Buy	Hold
Aug 06, 2024	H.C. Wainwright	Buy	Buy	Hold
Jun 18, 2024	H.C. Wainwright	Buy	Buy	Hold
May 23, 2024	H.C. Wainwright	Buy	Buy	Hold
Apr 17, 2024	Benchmark	Underperform	Underperform	Hold
Apr 17, 2024	H.C. Wainwright	Buy	Buy	Hold
Mar 13, 2024	H.C. Wainwright	Buy	Buy	Hold

Row per page

Go to

Clene's last stock rating was published by Canaccord Genuity on Oct 04, 2024. The company gave CLNN a "Buy" rating, the same as its previous rate.

Clene Financial Forecast

Clene Revenue Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$170.00K	$108.00K	-	$107.00K	$234.00K	$174.00K	$35.00K	$30.00K	$199.00K	$110.00K
Avg Forecast	$231.71K	$218.74K	$206.49K	$194.93K	$184.01K	$173.71K	$163.98K	$154.80K	$146.13K	$137.95K	$130.22K	$122.93K	$75.00K	$75.00K	$75.00K	$75.00K	$146.67K	$106.67K	$120.00K	$162.50K	$145.00K	$136.00K	$117.83K	$134.17K	$181.00K	$86.67K	$83.33K	$83.00K	$116.25K	$116.25K
High Forecast	$355.87K	$335.95K	$317.13K	$299.38K	$282.61K	$266.79K	$251.85K	$237.75K	$224.44K	$211.87K	$200.00K	$188.80K	$115.19K	$115.19K	$115.19K	$115.19K	$223.19K	$163.82K	$184.30K	$162.75K	$165.71K	$208.87K	$180.97K	$206.06K	$277.99K	$86.67K	$83.33K	$83.00K	$116.25K	$116.25K
Low Forecast	$130.49K	$123.18K	$116.28K	$109.77K	$103.63K	$97.82K	$92.34K	$87.17K	$82.29K	$77.69K	$73.33K	$69.23K	$42.23K	$42.23K	$42.23K	$42.23K	$63.77K	$60.07K	$67.58K	$162.25K	$124.28K	$76.59K	$66.36K	$75.55K	$101.93K	$86.67K	$83.33K	$83.00K	$116.25K	$116.25K
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	2	3	1	1	1	2	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.17%	0.79%	-	0.80%	1.29%	2.01%	0.42%	0.36%	1.71%	0.95%

Clene's average Quarter revenue forecast for Mar 24 based on 1 analysts is $162.50K, with a low forecast of $162.25K, and a high forecast of $162.75K. CLNN's average Quarter revenue forecast represents a -4.41% decrease compared to the company's last Quarter revenue of $170.00K (Dec 23).

Clene EBITDA Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	2	3	1	1	1	2	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-9.51M	$-9.54M	-	$-10.24M	$-10.21M	$-8.24M	$-12.89M	$-12.71M	$4.80M	$29.19M
Avg Forecast	$-139.03K	$-131.24K	$-123.89K	$-116.96K	$-110.41K	$-104.22K	$-98.39K	$-92.88K	$-87.68K	$-82.77K	$-78.14K	$-73.76K	$-45.00K	$-45.00K	$-45.00K	$-45.00K	$-88.00K	$-64.00K	$-72.00K	$-97.50K	$-87.00K	$-81.60K	$-70.70K	$-80.50K	$-108.60K	$-52.00K	$-50.00K	$-10.00	$-69.75K	$-69.75K
High Forecast	$-78.29K	$-73.91K	$-69.77K	$-65.86K	$-62.17K	$-58.69K	$-55.41K	$-52.30K	$-49.38K	$-46.61K	$-44.00K	$-41.54K	$-25.34K	$-25.34K	$-25.34K	$-25.34K	$-38.26K	$-36.04K	$-40.55K	$-97.35K	$-74.57K	$-45.95K	$-39.81K	$-45.33K	$-61.16K	$-52.00K	$-50.00K	$-8.00	$-69.75K	$-69.75K
Low Forecast	$-213.52K	$-201.57K	$-190.28K	$-179.63K	$-169.57K	$-160.07K	$-151.11K	$-142.65K	$-134.66K	$-127.12K	$-120.00K	$-113.28K	$-69.11K	$-69.11K	$-69.11K	$-69.11K	$-133.91K	$-98.29K	$-110.58K	$-97.65K	$-99.43K	$-125.32K	$-108.58K	$-123.63K	$-166.79K	$-52.00K	$-50.00K	$-13.00	$-69.75K	$-69.75K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	109.29%	116.94%	-	127.20%	94.04%	158.44%	257.85%	1271000.00%	-68.85%	-418.49%

1 analysts predict CLNN's average Quarter EBITDA for Mar 22 to be $-10.00, with a high of $-8.00 and a low of $-13.00. This is -100.00% lower than Clene's previous annual EBITDA (Dec 21) of $4.80M.

Clene Net Income Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	2	3	1	1	1	2	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-10.17M	$-2.42M	-	$-13.87M	$8.62M	$-12.13M	$3.90M	$-14.08M	$4.42M	$28.94M
Avg Forecast	$-1.24M	$-1.12M	$-1.04M	$-1.10M	$-1.53M	$-1.38M	$-1.28M	$-1.35M	$-1.52M	$-1.37M	$-1.28M	$-2.11M	$-4.49M	$-4.80M	$-4.79M	$-4.81M	$-6.30M	$-8.73M	$-9.89M	$-10.49M	$-9.44M	$-11.80M	$-16.18M	$-18.99M	$-4.50M	$-554.23M	$-515.74M	$-11.00	$-416.22M	$-518.99M
High Forecast	$-536.39K	$-483.68K	$-449.40K	$-473.76K	$-662.21K	$-597.02K	$-554.80K	$-584.84K	$-657.95K	$-593.34K	$-551.12K	$-912.98K	$-1.94M	$-2.07M	$-2.07M	$-2.08M	$-5.78M	$-3.77M	$-4.27M	$-4.53M	$-8.09M	$-5.10M	$-6.99M	$-8.21M	$-1.94M	$-554.23M	$-515.74M	$-9.00	$-416.22M	$-518.99M
Low Forecast	$-2.11M	$-1.90M	$-1.76M	$-1.86M	$-2.60M	$-2.34M	$-2.18M	$-2.30M	$-2.58M	$-2.33M	$-2.16M	$-3.58M	$-7.61M	$-8.14M	$-8.12M	$-8.17M	$-6.82M	$-14.80M	$-16.78M	$-17.80M	$-10.79M	$-20.03M	$-27.44M	$-32.23M	$-7.63M	$-554.23M	$-515.74M	$-14.00	$-416.22M	$-518.99M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.08%	0.20%	-	0.73%	-1.92%	0.02%	-0.01%	1280181.82%	-0.01%	-0.06%

Clene's average Quarter net income forecast for Mar 23 is $-18.99M, with a range of $-32.23M to $-8.21M. CLNN's average Quarter net income forecast represents a -320.49% decrease compared to the company's last Quarter net income of $8.62M (Dec 22).

Clene SG&A Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	2	3	1	1	1	2	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$3.32M	$3.67M	-	$3.18M	$4.26M	$3.34M	$4.19M	$4.38M	$2.07M	$4.40M
Avg Forecast	$5.09M	$4.81M	$4.54M	$4.28M	$4.04M	$3.82M	$3.60M	$3.40M	$3.21M	$3.03M	$2.86M	$2.70M	$1.65M	$1.65M	$1.65M	$1.65M	$3.22M	$2.34M	$2.64M	$3.57M	$3.19M	$2.99M	$2.59M	$2.95M	$3.98M	$1.90M	$1.82M	$4.00	$2.55M	$2.55M
High Forecast	$7.82M	$7.38M	$6.97M	$6.58M	$6.21M	$5.86M	$5.53M	$5.22M	$4.93M	$4.66M	$4.40M	$4.15M	$2.53M	$2.53M	$2.53M	$2.53M	$4.90M	$3.60M	$4.05M	$3.58M	$3.64M	$4.59M	$3.98M	$4.53M	$6.11M	$1.90M	$1.82M	$5.00	$2.55M	$2.55M
Low Forecast	$2.87M	$2.71M	$2.56M	$2.41M	$2.28M	$2.15M	$2.03M	$1.92M	$1.81M	$1.71M	$1.61M	$1.52M	$928.13K	$928.13K	$928.13K	$928.13K	$1.40M	$1.32M	$1.49M	$3.57M	$2.73M	$1.68M	$1.46M	$1.66M	$2.24M	$1.90M	$1.82M	$3.00	$2.55M	$2.55M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.04%	1.23%	-	1.08%	1.07%	1.76%	2.30%	1093750.00%	0.81%	1.73%

Clene's average Quarter SG&A projection for Mar 24 is $3.57M, based on 1 Wall Street analysts, with a range of $3.57M to $3.58M. The forecast indicates a 7.50% rise compared to CLNN last annual SG&A of $3.32M (Dec 23).

Clene EPS Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	2	3	1	1	1	2	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.08	$-0.02	-	$-0.18	$0.13	$-0.19	$0.06	$-0.22	$0.07	$0.47
Avg Forecast	$-0.19	$-0.17	$-0.16	$-0.17	$-0.23	$-0.21	$-0.20	$-0.21	$-0.23	$-0.21	$-0.19	$-0.32	$-0.68	$-0.73	$-0.73	$-0.73	$-0.96	$-1.33	$-1.51	$-1.60	$-1.44	$-1.80	$-2.47	$-2.90	$-0.69	$-4.31	$-4.01	$-3.90	$-3.24	$-4.04
High Forecast	$-0.08	$-0.07	$-0.07	$-0.07	$-0.10	$-0.09	$-0.08	$-0.09	$-0.10	$-0.09	$-0.08	$-0.14	$-0.30	$-0.32	$-0.32	$-0.32	$-0.88	$-0.57	$-0.65	$-0.69	$-1.23	$-0.78	$-1.07	$-1.25	$-0.30	$-4.31	$-4.01	$-3.90	$-3.24	$-4.04
Low Forecast	$-0.32	$-0.29	$-0.27	$-0.28	$-0.40	$-0.36	$-0.33	$-0.35	$-0.39	$-0.36	$-0.33	$-0.55	$-1.16	$-1.24	$-1.24	$-1.25	$-1.04	$-2.26	$-2.56	$-2.71	$-1.65	$-3.05	$-4.18	$-4.91	$-1.16	$-4.31	$-4.01	$-3.90	$-3.24	$-4.04
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.06%	0.01%	-	0.06%	-0.19%	0.04%	-0.02%	0.06%	-0.02%	-0.12%

According to 1 Wall Street analysts, Clene's projected average Quarter EPS for Mar 23 is $-2.90, with a low estimate of $-4.91 and a high estimate of $-1.25. This represents a -2328.08% decrease compared to CLNN previous annual EPS of $0.13 (Dec 22).

Clene Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
IPSC	Century Therapeutics	$1.26	$15.00	1090.48%	Buy
SNSE	Sensei Biotherapeutics	$0.50	$5.50	1000.00%	Buy
NGM	NGM Biopharmaceuticals	$1.54	$16.50	971.43%	Buy
NKTX	Nkarta	$2.50	$21.60	764.00%	Buy
HOWL	Werewolf Therapeutics	$1.64	$12.00	631.71%	Buy
MOLN	Molecular Partners	$5.20	$29.00	457.69%	Buy
IMNM	Immunome	$9.33	$30.33	225.08%	Buy
NUVB	Nuvation Bio	$2.58	$6.75	161.63%	Buy
ELYM	Eliem Therapeutics	$5.11	$13.00	154.40%	Buy
CLNN	Clene	$4.09	$10.00	144.50%	Buy
MLYS	Mineralys Therapeutics	$12.60	$30.00	138.10%	Buy
KZR	Kezar Life Sciences	$7.49	$17.50	133.64%	Buy
NXTC	NextCure	$1.30	$3.00	130.77%	Buy
FHTX	Foghorn Therapeutics	$7.86	$16.33	107.76%	Buy
GRPH	LENZ Therapeutics	$3.18	$4.00	25.79%	Hold
IKNA	Ikena Oncology	$1.70	$1.33	-21.76%	Buy
CYT	Cyteir Therapeutics	$3.02	$2.00	-33.77%	Sell

CLNN Forecast FAQ

Is Clene a good buy?

Yes, according to 6 Wall Street analysts, Clene (CLNN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 100.00% of CLNN's total ratings.

What is CLNN's price target?

Clene (CLNN) average price target is $10 with a range of $10 to $10, implying a 144.50% from its last price of $4.09. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Clene stock go up soon?

According to Wall Street analysts' prediction for CLNN stock, the company can go up by 144.50% (from the last price of $4.09 to the average price target of $10), up by 144.50% based on the highest stock price target, and up by 144.50% based on the lowest stock price target.

Can Clene stock reach $6?

CLNN's average twelve months analyst stock price target of $10 supports the claim that Clene can reach $6 in the near future.

What are Clene's analysts' financial forecasts?

Clene's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $676.51K (high $1.04M, low $380.97K), average EBITDA is $-406K (high $-229K, low $-623K), average net income is $-5.552M (high $-2.399M, low $-9.419M), average SG&A $14.87M (high $22.83M, low $8.37M), and average EPS is $-0.847 (high $-0.366, low $-1.436). CLNN's analysts financial forecasts for the fiscal year (Dec 2028) are as follows: average revenue is $851.87K (high $1.31M, low $479.72K), average EBITDA is $-511K (high $-288K, low $-785K), average net income is $-4.497M (high $-1.943M, low $-7.63M), average SG&A $18.72M (high $28.75M, low $10.54M), and average EPS is $-0.686 (high $-0.296, low $-1.164).

Did the CLNN's actual financial results beat the analysts' financial forecasts?

Based on Clene's last annual report (Dec 2023), the company's revenue was $654K, beating the average analysts forecast of $533K by 22.70%. Apple's EBITDA was $-40.54M, beating the average prediction of $-320K by 12576.71%. The company's net income was $-49.504M, missing the average estimation of $-56.417M by -12.25%. Apple's SG&A was $14.42M, beating the average forecast of $11.71M by 23.10%. Lastly, the company's EPS was $-0.0005, missing the average prediction of $-8.603 by -99.99%. In terms of the last quarterly report (Dec 2023), Clene's revenue was $170K, beating the average analysts' forecast of $145K by 17.24%. The company's EBITDA was $-9.508M, beating the average prediction of $-87K by 10828.74%. Clene's net income was $-10.173M, beating the average estimation of $-9.443M by 7.73%. The company's SG&A was $3.32M, beating the average forecast of $3.19M by 4.25%. Lastly, the company's EPS was $-0.0792, missing the average prediction of $-1.44 by -94.50%